People · Operator
Named in public records as an officer, director or promoter · active 2015–2017 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precipio, Inc. | — | Biotechnology | Series B | $67.0M | $32.2M | 2017 |
| Watermark Medical Holdings, Inc. | — | Healthtech | Series A | $26.2M | $75.0M | 2015 |
Carl Iberger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl Iberger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Cohen | 1 | 38 |
| David Lewis | 1 | 7 |
| John Sculley | 1 | 6 |
| Antonius Schuh | 1 | 5 |
| Rodney Markin | 1 | 4 |
| DAN RYAN | 1 | 4 |
| Michael Luther | 1 | 4 |
| RODNEY S MARKIN | 1 | 3 |
| Doug Fisher | 1 | 3 |
| Drew Graham | 1 | 3 |
| Jim N. Hodge | 1 | 2 |
| Sean Heyniger | 1 | 2 |
| John N. Sculley | 1 | 2 |
| Dr. Richard N. Bogan | 1 | 2 |
| Peter N. Callahan | 1 | 2 |
| Drew N. Graham | 1 | 2 |
| Charles N. Alvarez | 1 | 2 |
| Jacob N. Lamm | 1 | 2 |
| MARK P. COLONNESE | 1 | 2 |
| John D. Thompson | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.